Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation
Open Access
- 21 February 2019
- journal article
- research article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 104 (11), 2314-2323
- https://doi.org/10.3324/haematol.2019.216101
Abstract
Pathophysiology of graft failure occurring after allogeneic hematopoietic stem cell transplantation still remains elusive. We measured serum levels of several different cytokines/chemokines in 15 children experiencing graft failure, comparing their values with those of 15 controls who had sustained donor cell engraftment. Already at day +3 after transplantation, patients developing graft failure had serum levels of IFNγ and CXCL9, a chemokine specifically induced by IFNγ, significantly higher than those of controls (8859±7502 versus 0 pg/ml, p=0.03, and 1514.0±773 versus 233.6±50.1 pg/ml, p=0.0006, respectively). The role played by IFNγ in hematopoietic stem cell transplantation-related graft failure was further supported by the observation that a rat anti-mouse IFNγ-neutralizing monoclonal antibody promotes donor cell engraftment in Ifngr1-/- mice receiving an allograft. In comparison to controls, analysis of bone marrow-infiltrating T lymphocytes in patients experiencing graft failure documented a predominance of effector memory CD8+ cells, which showed markers of activation (over-expression of CD95 and down-regulation of CD127) and exhaustion (CD57, CD279, CD223 and CD366). Finally, we obtained successful donor engraftment in 2 out of 3 children with primary hemophagocytic lymphohistiocytosis who, after experiencing graft failure, were re-transplanted from the same HLA-haploidentical donor under the compassionate use coverage of emapalumab, an anti-IFNγ monoclonal antibody recently approved by the Food and Drug Administration for treatment of patients with primary hemophagocytic lymphohistiocytosis. Altogether, these results suggest that IFNγ pathway plays a major role in graft failure occurring after hematopoietic stem cell transplantation. Increased serum levels of IFNγ and CXCL9 represent potential biomarkers useful for early diagnosis of graft failure and provide the rationale for exploring the therapeutic/preventive role of targeted neutralization of IFNγ.Keywords
This publication has 44 references indexed in Scilit:
- Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCTBone Marrow Transplantation, 2011
- CXCR3 ligands: redundant, collaborative and antagonistic functionsImmunology & Cell Biology, 2011
- Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infectionProceedings of the National Academy of Sciences, 2010
- High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adultsBritish Journal of Haematology, 2009
- IFN-γ Mediates the Rejection of Haematopoietic Stem Cells in IFN-γR1-Deficient HostsPLoS Medicine, 2008
- Hematopoietic stem cell transplantation for complete IFN-γ receptor 1 deficiency: A multi-institutional surveyThe Journal of Pediatrics, 2004
- An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorderBlood, 2004
- Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killingBlood, 2003
- Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantationBone Marrow Transplantation, 2002
- Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.The Journal of Experimental Medicine, 1987